Review



c parapsilosis atcc 90 018  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC c parapsilosis atcc 90 018
    In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. <t>parapsilosis</t> NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019
    C Parapsilosis Atcc 90 018, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 417 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c parapsilosis atcc 90 018/product/ATCC
    Average 96 stars, based on 417 article reviews
    c parapsilosis atcc 90 018 - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Synergistic effect of lactoferrin combined with fluconazole to overcome antifungal resistance in Candida species"

    Article Title: Synergistic effect of lactoferrin combined with fluconazole to overcome antifungal resistance in Candida species

    Journal: Annals of Clinical Microbiology and Antimicrobials

    doi: 10.1186/s12941-025-00836-1

    In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. parapsilosis NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019
    Figure Legend Snippet: In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. parapsilosis NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019

    Techniques Used: In Vitro, Activity Assay, Control



    Similar Products

    96
    ATCC c parapsilosis atcc 90 018
    In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. <t>parapsilosis</t> NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019
    C Parapsilosis Atcc 90 018, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c parapsilosis atcc 90 018/product/ATCC
    Average 96 stars, based on 1 article reviews
    c parapsilosis atcc 90 018 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. parapsilosis NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019

    Journal: Annals of Clinical Microbiology and Antimicrobials

    Article Title: Synergistic effect of lactoferrin combined with fluconazole to overcome antifungal resistance in Candida species

    doi: 10.1186/s12941-025-00836-1

    Figure Lengend Snippet: In vitro activity of the combination of fluconazole (8 µg/mL) and lactoferrin (8 µg/mL) against fluconazole resistant isolates ( a ) C. albicans UPV 15–147 and ( b ) C. albicans UPV 15–157; fluconazole resistant control strains ( c ) C. albicans ATCC 64124 and ( d ) C. parapsilosis NCPF 3153; and fluconazole susceptible control strains ( e ) C. albicans NCPF 3104 and ( f ) C. parapsilosis ATCC 22019

    Article Snippet: C. parapsilosis ATCC 90,018 , 0.5 , , 32 , , 0.25 , , 16 , 1.00 , NI , NI.

    Techniques: In Vitro, Activity Assay, Control